Used primarily in the treatment of hyperlipidemia and prevention of cardiovascular diseases. It functions as a prodrug that, upon hydrolysis in the body, releases pitavastatin, a potent HMG-CoA reductase inhibitor. This inhibition reduces cholesterol biosynthesis in the liver, leading to upregulation of LDL receptors and increased clearance of LDL from the bloodstream. Commonly prescribed to lower LDL cholesterol and triglyceride levels while moderately increasing HDL cholesterol. Employed in patients at risk for atherosclerosis, heart attack, and stroke, especially those with type 2 diabetes or metabolic syndrome. Its high potency and favorable pharmacokinetic profile allow for low-dose regimens with minimal drug interactions.